<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03321110</url>
  </required_header>
  <id_info>
    <org_study_id>MOST106-2410-H-030-065</org_study_id>
    <nct_id>NCT03321110</nct_id>
  </id_info>
  <brief_title>Effects of Coenzyme Q10 Supplementation on Oxidative Stress, Antioxidant Capacity, Inflammatory Responses, Fatigue Elimination, and Exercise Performance in Athletes</brief_title>
  <official_title>Effects of Coenzyme Q10 Supplementation on Oxidative Stress, Antioxidant Capacity, Inflammatory Responses, Fatigue Elimination, and Exercise Performance in Athletes From Different Sports: Cross-sectional, Interventional, and Follow-up Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study are 1) to compare the differences in plasma coenzyme Q10, oxidative
      stress, antioxidant capacity, muscle impairment, fatigue recovery, and inflammation and
      exercise performances in athletes (i.e., soccer, and taekwondo players) and healthy
      non-athletes; 2) to investigate the relationship between plasma coenzyme Q10, oxidative
      stress, antioxidant capacity, muscle impairment, fatigue recovery, and inflammation and
      exercise performances; 3) to explore the influence on plasma coenzyme Q10, oxidative stress,
      antioxidant capacity, muscle impairment, fatigue recovery, and inflammation and exercise
      performances after 12 weeks of coenzyme Q10 intervention (150 mg/day and 300 mg/day).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The long-term high-amount and -intensity exercise training could cause oxidative damage,
      muscle impairment, inflammation and exercise fatigue to athletes easily. Such above
      conditions will affect the exercise performances and health of athletes. The aims of the
      study are 1) to compare the differences in plasma coenzyme Q10, oxidative stress, antioxidant
      capacity, muscle impairment, fatigue recovery, and inflammation and exercise performances in
      athletes (i.e., soccer, and taekwondo players) and healthy non-athletes; 2) to investigate
      the relationship between plasma coenzyme Q10, oxidative stress, antioxidant capacity, muscle
      impairment, fatigue recovery, and inflammation and exercise performances; 3) to explore the
      influence on plasma coenzyme Q10, oxidative stress, antioxidant capacity, muscle impairment,
      fatigue recovery, and inflammation and exercise performances after 12 weeks of coenzyme Q10
      intervention (150 mg/day and 300 mg/day). Eventually, these results of this study can provide
      the information for the known to improve the oxidative stress, anti-oxidation and
      inflammation internal to the bodies of athletes for various competitions. As a consequence,
      the athletic performances can be further enhanced.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>placebo-control</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>malondialdehyde (MDA)</measure>
    <time_frame>12 weeks</time_frame>
    <description>MDA (micromol/L) will measure by thiobarbituric acid reacting substance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Antioxidant capacity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Total antioxidant capacity (TAC) was measured by a Trolox equivalent antioxidant capacity assay in serum and erythrocytes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>high sensitivity C-reactive protein (hs-CRP)</measure>
    <time_frame>12 weeks</time_frame>
    <description>hs-CRP will measure by immunoturbidimetry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>creatine kinase (CK)</measure>
    <time_frame>12 weeks</time_frame>
    <description>serum CK will measure by enzymatic method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate dehydrogenase (LDH)</measure>
    <time_frame>12 weeks</time_frame>
    <description>serum LDH will measure by enzymatic method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>one-repetition maximum (1-RM)</measure>
    <time_frame>12 weeks</time_frame>
    <description>1RM measurements will report in kilograms for data analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>12 weeks</time_frame>
    <description>mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1C</measure>
    <time_frame>12 weeks</time_frame>
    <description>HbA1C will measure by an automated glycated hemoglobin analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>12 weeks</time_frame>
    <description>insulin will measure by an automated chemistry analyzer</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Athlete</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Q10-150</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>coenzyme Q10 150 mg/d.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Q10-300</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>coenzyme Q10 300 mg/d.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (dextrin)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coenzyme Q10</intervention_name>
    <description>150 mg or 300 mg</description>
    <arm_group_label>Q10-150</arm_group_label>
    <arm_group_label>Q10-300</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Athletes (soccer and taekwondo players)

        Exclusion Criteria:

          -  Antioxidant vitamins users

          -  Statins or Aspirin therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chung Shan Medical University</name>
      <address>
        <city>Taichung</city>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 13, 2017</study_first_submitted>
  <study_first_submitted_qc>October 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2017</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>LJ Hwu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ubiquinone</mesh_term>
    <mesh_term>Coenzyme Q10</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

